Clinical Study

Neoadjuvant Chemotherapy in Locally Advanced and Borderline Resectable Nonsquamous Sinonasal Tumors (Esthesioneuroblastoma and Sinonasal Tumor with Neuroendocrine Differentiation)

Table 3

Adverse events in accordance with CTCAE version 4.03 observed during NACT. Numbers shown are actual patient numbers.

ToxicityGrade 3Grade 4

Anemia0200
Neutropenia0604
Thrombocytopenia0000
Febrile neutropenia0102
Nausea0000
Vomiting0000
Diarrhea0100
Increased serum creatinine0000
Transaminitis (raised SGOT/PT)0000
Hyponatremia0705
Hypokalemia0000
Hyperkalemia0000